Pentobarbital reduces rhabdomyolysis-induced acute renal failure in conscious rats

Journal of Trauma - Injury, Infection and Critical Care

Volumn 67, Issue 1, 2009, Pages 132-138

  Subeq, Yi Maun ^a,b   Wu, Wen Tien ^a   Lee, Chung Jen ^a   Lee, Ru Ping ^a   Yang, Fwu Lin ^a,b   Hsu, Bang Gee ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute renal failure; Pentobarbital; Rhabdomyolysis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; GLYCEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITROGEN; PENTOBARBITAL; UREA; UVOMORULIN; BENZODIAZEPINE RECEPTOR AFFECTING AGENT;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RHABDOMYOLYSIS; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; COGNITION; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; COGNITION; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; GABA MODULATORS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES; MALE; NF-KAPPA B; PENTOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; RHABDOMYOLYSIS; TREATMENT OUTCOME;

EID: 70350447603     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318186253d     Document Type: Article

References (24)

1. Sauret JM, Marinides G, Wang GK. Rhabdomyolysis. Am Fam Physician. 2002;65:907-912.
2. Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Intern Med. 2007;18:90-100.
3. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996;49:314-326.
4. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis-an overview for clinicians. Crit Care. 2005;9:158-169.
5. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000;11:1553-1556.
6. Fujitsuka N, Goto K, Takeda S, Aburada M. The diuretic effect of Sairei-to is mediated by nitric oxide production in pentobarbitalanesthetized rats. J Pharmacol Sci. 2004;94:185-191.
7. Cravero JP, Blike GT. Review of pediatric sedation. Anesth Analg. 2004;99:1355-1364.
8. Lee MW, Deppe SA, Sipperly ME, Barrette RR, Thompson DR. The efficacy of barbiturate coma in the management of uncontrolled intracranial hypertension following neurosurgical trauma. J Neurotrauma. 1994;11:325-331.
9. Yang FL, Li CH, Hsu BG, et al. The reduction of TNF-α release and tissue damages by pentobarbital in the experimental endotoxemia model. Shock. 2007;28:309-316.
10. Kao SJ, Su CF, Liu DD, Chen HI. Endotoxin-induced acute lung injury and organ dysfunction are attenuated by pentobarbital anaesthesia. Clin Exp Pharmacol Physiol. 2007;34:480-487.
11. Drafts BC, Fisher JL. Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital. J Pharmacol Exp Ther. 2006;318:1094-1101.
12. Sasaki S, Yokozawa T, Cho EJ, Oowada S, Kim M. Protective role of gamma-aminobutyric acid against chronic renal failure in rats. J Pharm Pharmacol. 2006;58:1515-1525.
13. Hsu BG, Lee RP, Yang FL, Harn HJ, Chen HI. Post-treatment with N-acetylcysteine ameliorates the endotoxin shock-induced organ damage in conscious rats. Life Sci. 2006;79:2010-2016.
14. Chen CH, Lee RP, Wu WT, Liao KW, Hsu N, Hsu BG. Fluvastatin attenuate endotoxin shock induced organ damage in conscious rats. Resuscitation. 2007;74:166-174.
15. Jo SK, Ko GJ, Boo CS, Cho WY, Kim HK. Heat preconditioning attenuates renal injury in ischemic ARF in rats: role of heat-shock protein 70 on NF-kappa B-mediated inflammation and on tubular cell injury. J Am Soc Nephrol. 2006;17:3082-3092.
16. Akmal M, Massry SG. Reversible hepatic dysfunction associated with rhabdomyolysis. Am J Nephrol. 1990;10:49-52.
17. Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med. 1998;148:1553-1557.
18. Lochhead KM, Kharasch ED, Zager RA. Anesthetic effects on the glycerol model of rhabdomyolysis-induced acute renal failure in rats. J Am Soc Nephrol. 1998;9:305-309.
19. Bush KT, Tsukamoto T, Nigam SK. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia Am J Physiol Renal Physiol. 2000;278:F847-F852.
20. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007;212:209-217.
21. Burns WC, Twigg SM, Forbes JM, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol. 2006;17:2484-2494.
22. Sitte HH, Singer EA, Scholze P. Bi-directional transport of GABA in human embryonic kidney (HEK-293) cells stably expressing the rat GABA transporter GAT-1. Br J Pharmacol. 2002;135:93-102.
23. Coote JH. A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney. Exp Physiol. 2005;90:169-173.
24. Akk G, Bracamontes J, Steinbach JH. Activation of GABA (A) receptors containing the alpha4 subunit by GABA and pentobarbital. J Physiol. 2004;556:387-399.